Class information for:
Level 2: SGLT2 INHIBITOR//METFORMIN//DPP 4 INHIBITOR

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1572904
202 3       DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES 52563
628 2             SGLT2 INHIBITOR//METFORMIN//DPP 4 INHIBITOR 14172
320 1                   DPP 4 INHIBITOR//EXENATIDE//LIRAGLUTIDE 3688
582 1                   ATP SENSITIVE K CHANNEL//K ATP CHANNEL//ATP SENSITIVE POTASSIUM CHANNEL 3308
4461 1                   GLIMEPIRIDE//JTT 608//SECONDARY FAILURE 1814
7314 1                   SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN 1407
7692 1                   METFORMIN//LACTIC ACIDOSIS//BIGUANIDES 1363
14436 1                   ACARBOSE//MIGLITOL//ALPHA GLUCOSIDASE INHIBITOR 800
16588 1                   METFORMIN HYDROCHLORIDE//GLIMEPIRIDE//PIOGLITAZONE HYDROCHLORIDE 673
19910 1                   NATEGLINIDE//MITIGLINIDE//REPAGLINIDE 506
22721 1                   GLICLAZIDE//ARTIFICIAL CELL MICROENCAPSULATION//BIOTECHNOL DRUG DEV 393
28665 1                   CANDIDATE FORM SELECTION//CRITICAL SOLUBILITIES//HYGRODYNAMICS 220

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 SGLT2 INHIBITOR authKW 676297 2% 94% 325
2 METFORMIN authKW 591313 7% 26% 1043
3 DPP 4 INHIBITOR authKW 541656 2% 73% 332
4 SITAGLIPTIN authKW 458325 2% 65% 318
5 EXENATIDE authKW 453689 2% 64% 318
6 LIRAGLUTIDE authKW 440670 2% 61% 324
7 DIPEPTIDYL PEPTIDASE 4 INHIBITOR authKW 426897 2% 75% 256
8 GLIBENCLAMIDE authKW 386775 3% 36% 479
9 DAPAGLIFLOZIN authKW 351168 1% 92% 171
10 CANAGLIFLOZIN authKW 329331 1% 96% 154

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Endocrinology & Metabolism 98441 32% 1% 4586
2 Pharmacology & Pharmacy 27340 27% 0% 3825
3 Medicine, General & Internal 4810 10% 0% 1418
4 Cardiac & Cardiovascular System 3295 7% 0% 1024
5 Physiology 2255 5% 0% 750
6 Medicine, Research & Experimental 1565 5% 0% 729
7 Chemistry, Medicinal 1233 4% 0% 501
8 Peripheral Vascular Diseases 855 3% 0% 431
9 Primary Health Care 313 1% 0% 80
10 Toxicology 234 2% 0% 289

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 DIABET NUTR METAB DISORDERS 33485 0% 31% 49
2 PHARMACODYNAM THER EUT 30571 0% 81% 17
3 THER EUT AREA METAB 28885 0% 100% 13
4 LILLY DIABET 23690 0% 67% 16
5 DIABET 22417 2% 3% 319
6 BIOTECHNOL DRUG DEV 19973 0% 43% 21
7 PHARMACODYNAMIE THER EUT 18134 0% 58% 14
8 OCHSNER DIABET CLIN UNIT 16649 0% 50% 15
9 ENDOCRINOL METAB 16064 3% 2% 406
10 DIABET METAB TRANSLAT MED UNIT 14928 0% 61% 11

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 DIABETES OBESITY & METABOLISM 312923 4% 25% 574
2 DIABETES THERAPY 81790 1% 38% 96
3 DIABETES CARE 44703 3% 4% 485
4 JOURNAL OF DIABETES INVESTIGATION 31900 1% 15% 97
5 DIABETES & METABOLISM 30532 1% 7% 200
6 CARDIOVASCULAR DIABETOLOGY 27715 1% 10% 129
7 DIABETES RESEARCH AND CLINICAL PRACTICE 24744 2% 5% 249
8 DIABETIC MEDICINE 13640 1% 3% 191
9 DIABETOLOGIA 12408 2% 3% 221
10 DIABETES 10815 2% 2% 248

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 SGLT2 INHIBITOR 676297 2% 94% 325 Search SGLT2+INHIBITOR Search SGLT2+INHIBITOR
2 METFORMIN 591313 7% 26% 1043 Search METFORMIN Search METFORMIN
3 DPP 4 INHIBITOR 541656 2% 73% 332 Search DPP+4+INHIBITOR Search DPP+4+INHIBITOR
4 SITAGLIPTIN 458325 2% 65% 318 Search SITAGLIPTIN Search SITAGLIPTIN
5 EXENATIDE 453689 2% 64% 318 Search EXENATIDE Search EXENATIDE
6 LIRAGLUTIDE 440670 2% 61% 324 Search LIRAGLUTIDE Search LIRAGLUTIDE
7 DIPEPTIDYL PEPTIDASE 4 INHIBITOR 426897 2% 75% 256 Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR
8 GLIBENCLAMIDE 386775 3% 36% 479 Search GLIBENCLAMIDE Search GLIBENCLAMIDE
9 DAPAGLIFLOZIN 351168 1% 92% 171 Search DAPAGLIFLOZIN Search DAPAGLIFLOZIN
10 CANAGLIFLOZIN 329331 1% 96% 154 Search CANAGLIFLOZIN Search CANAGLIFLOZIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 2


rank cluster_id2 link
1 603 DIABETES TECHNOLOGY & THERAPEUTICS//TYPE 1 DIABETES//INSULIN GLARGINE
2 138 BETA CELL//ISLET TRANSPLANTATION//ISLET
3 1307 THIAZOLIDINEDIONES//PPAR GAMMA//PIOGLITAZONE
4 624 DIABETES EDUCATOR//DIABETES CARE//DIABETES
5 1632 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM//INTRAMYOCELLULAR LIPIDS//GLUCONEOGENESIS
6 1479 DIPEPTIDYL PEPTIDASE IV//CD26//PROLIDASE
7 1955 HYPERGLYCEMIA//DIABETIC CARDIOMYOPATHY//INTENSIVE INSULIN THERAPY
8 3039 CONGENITAL HYPERINSULINISM//HYPERINSULINISM//PREOPERATIVE FASTING
9 1645 PHYSIOL MORPHOL//FRUCTOSE//INSULIN RESISTANCE
10 1014 INSULIN RECEPTOR//GLUT4//GLYCOSYLPHOSPHATIDYLINOSITOL

Go to start page